New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.

Related Keywords

Burdun Iliya ,Ad Neuroimaging Initiative ,Nature Medicine ,Mini Mental State Examination ,Geriatric Depression Scale ,Hachinski Ischemic Scale ,Columbia Suicide Severity Rating Scale ,Scale Cognitive Subscale ,